Demonstrates that surfactant protein D promotes pancreatic cell regeneration, improving glucose metabolism.
Pancreatic endocrine dysfunction following acute pancreatitis (AP) can lead to glucose intolerance and even diabetes. Surfactant protein D (SP-D), as an immune regulatory molecule, has not yet been clarified whether it participates in the regeneration of pancreatic acinar cells and β-cells by modulating the Notch pathway, thereby improving abnormal glucose metabolism. This study aimed to elucidate the role and mechanism of SP-D in promoting the regeneration of pancreatic secretory cells following AP and preventing post-pancreatitis diabetes by regulating the activity of the Notch pathway. Using wild-type and SP-D gene knockout (SP-D⁻/⁻) mice as models, dynamic observations were made after AP induction by Cerulein. Western blot analysis of pancreatic tissue revealed that in the SP-D⁻/⁻-AP group (DG), the key Notch pathway molecules NICD and Hes1 were persistently upregulated; the expression of acinar cell regeneration marker SOX9 and β-cell precursor differentiation marker NGN3 was reduced, and the recovery of the β-cell function marker insulin was delayed. Glucose metabolism testing revealed that the DG had significantly elevated fasting blood glucose (7.6 ± 0.5 mmol/L) at 30 d and an increased area under the curve in the oral glucose tolerance test. Sustained elevation of serum amylase and insufficient insulin secretion, with a markedly delayed repair process. SP-D promotes the regeneration and functional recovery of pancreatic acinar cells and β-cells by inhibiting the overactivation of the Notch pathway, thereby improving abnormal glucose metabolism following AP.
No takes yet. Share an insight, caveat, or question.
Jiexin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: